CVE-2017-13993
CVE-2017-13993 is a high-severity vulnerability in I-sens Smartlog Diabetes Management Software with a CVSS 3.x base score of 7.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-427.
Key facts
- Severity: High (CVSS 3.x base score 7.8)
- CVSS v2: 9.3
- EPSS exploit prediction: 2% (75th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-427
- Affected product: I-sens Smartlog Diabetes Management Software
- Published:
- Last modified:
Description
An Uncontrolled Search Path or Element issue was discovered in i-SENS SmartLog Diabetes Management Software, Version 2.4.0 and prior versions. An uncontrolled search path element vulnerability has been identified which could be exploited by placing a specially crafted DLL file in the search path. If the malicious DLL is loaded prior to the valid DLL, an attacker could execute arbitrary code on the system. This vulnerability does not affect the connected blood glucose monitor and would not impact delivery of therapy to the patient.
Frequently asked questions
- What is CVE-2017-13993?
- An Uncontrolled Search Path or Element issue was discovered in i-SENS SmartLog Diabetes Management Software, Version 2.4.0 and prior versions. An uncontrolled search path element vulnerability has been identified which could be exploited by placing a specially crafted DLL file in the search path. If the malicious DLL is loaded prior to the valid DLL, an attacker could execute arbitrary code on the system. This vulnerability does not affect the connected blood glucose monitor and would not impact delivery of therapy to the patient.
- How severe is CVE-2017-13993?
- CVE-2017-13993 has a CVSS 3.x base score of 7.8, rated high severity. It is exploitable over local access with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is high, integrity high, and availability high.
- Is CVE-2017-13993 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 2% (75th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2017-13993?
- CVE-2017-13993 affects I-sens Smartlog Diabetes Management Software. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2017-13993?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
- When was CVE-2017-13993 published?
- CVE-2017-13993 was published on 2017-10-05 and last updated on 2026-06-17.
References
Affected products (1)
- cpe:2.3:a:i-sens:smartlog_diabetes_management_software:*:*:*:*:*:*:*:*
Other CWE-427 (Uncontrolled Search Path Element) vulnerabilities
- CVE-2025-4981 — Critical (CVSS 9.9): Mattermost versions 10.5.x <= 10.5.5, 9.11.x <= 9.11.15, 10.8.x <= 10.8.0, 10.7.x <= 10.7.2, 10.6.x <= 10.6.5 fail to…
- CVE-2025-69599 — Critical (CVSS 9.8): RayVentory Scan Engine through 12.6 Update 8 allows attackers to gain privileges if they control the value of the PATH…
- CVE-2019-25268 — Critical (CVSS 9.8): NREL BEopt 2.8.0.0 contains a DLL hijacking vulnerability that allows attackers to load arbitrary libraries by tricking…
- CVE-2023-53959 — Critical (CVSS 9.8): FileZilla Client 3.63.1 contains a DLL hijacking vulnerability that allows attackers to execute malicious code by…
- CVE-2025-65741 — Critical (CVSS 9.8): Sublime Text 3 Build 3208 or prior for MacOS is vulnerable to Dylib Injection. An attacker could compile a .dylib file…
- CVE-2024-23054 — Critical (CVSS 9.8): An issue in Plone Docker Official Image 5.2.13 (5221) open-source software that could allow for remote code execution…
Browse all CWE-427 (Uncontrolled Search Path Element) vulnerabilities →